D.E. Shaw & Co’s Chemed CHE Stock Holding History

D.E. Shaw & Co’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-17,400	Closed	-$9.21M	–	5569
2021 Q4	$9.21M	Buy	+17,400	New	+$8.35M	0.01%	1735
2021 Q3	–	Sell	-11,600	Closed	-$5.5M	–	4985
2021 Q2	$5.5M	Hold	11,600	–	–	﹤0.01%	1954
2021 Q1	$5.33M	Buy	+11,600	New	+$5.69M	0.01%	1790
2020 Q2	–	Sell	-4,100	Closed	-$1.78M	–	4010
2020 Q1	$1.78M	Sell	4,100 -4,000	-49%	-$1.79M	﹤0.01%	2263
2019 Q4	$3.56M	Buy	8,100 +4,100	+103%	+$1.72M	﹤0.01%	2011
2019 Q3	$1.67M	Buy	+4,000	New	+$1.63M	﹤0.01%	2494
2018 Q4	–	Sell	-2,800	Closed	-$895K	–	3775
2018 Q3	$895K	Sell	2,800 -15,000	-84%	-$4.78M	﹤0.01%	2760
2018 Q2	$5.73M	Buy	+17,800	New	+$5.57M	0.01%	1436
2013 Q3	–	Sell	-3,000	Closed	-$217K	–	4301
2013 Q2	$217K	Buy	+3,000	New	+$220K	﹤0.01%	3722

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

D.E. Shaw & Co's CHE Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Chemed (CHE) stake by 86% in Q2 2026, selling an estimated $15.5M and leaving 6,160 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2894.

D.E. Shaw & Co first reported a position in CHE in Q3 2014 and has held it in 37 quarters since. The position peaked at $36.9M in Q2 2018. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

D.E. Shaw & Co held 6,160 shares of Chemed worth $2.87M as of Q2 2026.
D.E. Shaw & Co sold 36,749 Chemed shares in Q2 2026, an estimated $15.5M.
Chemed made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #2894 holding.
D.E. Shaw & Co first reported a position in Chemed in Q3 2014 and has held it in 37 quarters since.
D.E. Shaw & Co's Chemed position peaked at $36.9M in Q2 2018.
532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.